25th Annual South Miami Hospital Harry Kapp Symposium Evaluation

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	0
Optimization of lung cancer screening.	Optimization of lung cancer screening. - 5	Optimization of lung cancer screening. - 4	Optimization of lung cancer screening. - 3	Optimization of lung cancer screening. - 2	Optimization of lung cancer screening. - 1	Optimization of lung cancer screening. - 0
Implement optimal treatment for incidental lung nodule.	Implement optimal treatment for incidental lung nodule. - 5	Implement optimal treatment for incidental lung nodule. - 4	Implement optimal treatment for incidental lung nodule. - 3	Implement optimal treatment for incidental lung nodule. - 2	Implement optimal treatment for incidental lung nodule. - 1	Implement optimal treatment for incidental lung nodule. - 0
Discuss the different drugs available for pulmonary hypertension.	Discuss the different drugs available for pulmonary hypertension. - 5	Discuss the different drugs available for pulmonary hypertension. - 4	Discuss the different drugs available for pulmonary hypertension. - 3	Discuss the different drugs available for pulmonary hypertension. - 2	Discuss the different drugs available for pulmonary hypertension. - 1	Discuss the different drugs available for pulmonary hypertension. - 0
Determine the best drug for the appropriate patient.	Determine the best drug for the appropriate patient. - 5	Determine the best drug for the appropriate patient. - 4	Determine the best drug for the appropriate patient. - 3	Determine the best drug for the appropriate patient. - 2	Determine the best drug for the appropriate patient. - 1	Determine the best drug for the appropriate patient. - 0
Review the racial and ethnicity disparities in asthma clinical presentation and severity of disease.	Review the racial and ethnicity disparities in asthma clinical presentation and severity of disease. - 5	Review the racial and ethnicity disparities in asthma clinical presentation and severity of disease. - 4	Review the racial and ethnicity disparities in asthma clinical presentation and severity of disease. - 3	Review the racial and ethnicity disparities in asthma clinical presentation and severity of disease. - 2	Review the racial and ethnicity disparities in asthma clinical presentation and severity of disease. - 1	Review the racial and ethnicity disparities in asthma clinical presentation and severity of disease. - 0
Distinguish approaches to asthma management among different ethnicity groups.	Distinguish approaches to asthma management among different ethnicity groups. - 5	Distinguish approaches to asthma management among different ethnicity groups. - 4	Distinguish approaches to asthma management among different ethnicity groups. - 3	Distinguish approaches to asthma management among different ethnicity groups. - 2	Distinguish approaches to asthma management among different ethnicity groups. - 1	Distinguish approaches to asthma management among different ethnicity groups. - 0
Distinguish PAH from other groups of Pulmonary Hypertension.	Distinguish PAH from other groups of Pulmonary Hypertension. - 5	Distinguish PAH from other groups of Pulmonary Hypertension. - 4	Distinguish PAH from other groups of Pulmonary Hypertension. - 3	Distinguish PAH from other groups of Pulmonary Hypertension. - 2	Distinguish PAH from other groups of Pulmonary Hypertension. - 1	Distinguish PAH from other groups of Pulmonary Hypertension. - 0
Delineate diagnostic principles in PAH.	Delineate diagnostic principles in PAH. - 5	Delineate diagnostic principles in PAH. - 4	Delineate diagnostic principles in PAH. - 3	Delineate diagnostic principles in PAH. - 2	Delineate diagnostic principles in PAH. - 1	Delineate diagnostic principles in PAH. - 0
Identify the differences between academic and community physicians in diagnosing idiopathic pulmonary fibrosis (IPF).	Identify the differences between academic and community physicians in diagnosing idiopathic pulmonary fibrosis (IPF). - 5	Identify the differences between academic and community physicians in diagnosing idiopathic pulmonary fibrosis (IPF). - 4	Identify the differences between academic and community physicians in diagnosing idiopathic pulmonary fibrosis (IPF). - 3	Identify the differences between academic and community physicians in diagnosing idiopathic pulmonary fibrosis (IPF). - 2	Identify the differences between academic and community physicians in diagnosing idiopathic pulmonary fibrosis (IPF). - 1	Identify the differences between academic and community physicians in diagnosing idiopathic pulmonary fibrosis (IPF). - 0
Assess key clinical, radiologic and pathologic challenges in diagnosing IPF.	Assess key clinical, radiologic and pathologic challenges in diagnosing IPF. - 5	Assess key clinical, radiologic and pathologic challenges in diagnosing IPF. - 4	Assess key clinical, radiologic and pathologic challenges in diagnosing IPF. - 3	Assess key clinical, radiologic and pathologic challenges in diagnosing IPF. - 2	Assess key clinical, radiologic and pathologic challenges in diagnosing IPF. - 1	Assess key clinical, radiologic and pathologic challenges in diagnosing IPF. - 0

How effective were the following speakers in meeting their learning objectives? *

Scoring key: 5=Very effective, 4= Effective, 3= Somewhat effective, 2= Slightly effective, 1= Completely Ineffective Speakers are listed according to the lecture schedule.

	5	4	3	2	1
Pulmonary Hypertension-Resolving the conundrum of Medical Therapy - Javier Jimenez, M.D.	Pulmonary Hypertension-Resolving the conundrum of Medical Therapy - Javier Jimenez, M.D. - 5	Pulmonary Hypertension-Resolving the conundrum of Medical Therapy - Javier Jimenez, M.D. - 4	Pulmonary Hypertension-Resolving the conundrum of Medical Therapy - Javier Jimenez, M.D. - 3	Pulmonary Hypertension-Resolving the conundrum of Medical Therapy - Javier Jimenez, M.D. - 2	Pulmonary Hypertension-Resolving the conundrum of Medical Therapy - Javier Jimenez, M.D. - 1
Pulmonary Hypertension, Disease with Multiple Facets- Franck Rahaghi, M.D.	Pulmonary Hypertension, Disease with Multiple Facets- Franck Rahaghi, M.D. - 5	Pulmonary Hypertension, Disease with Multiple Facets- Franck Rahaghi, M.D. - 4	Pulmonary Hypertension, Disease with Multiple Facets- Franck Rahaghi, M.D. - 3	Pulmonary Hypertension, Disease with Multiple Facets- Franck Rahaghi, M.D. - 2	Pulmonary Hypertension, Disease with Multiple Facets- Franck Rahaghi, M.D. - 1
Indolent Lung Cancer: The Cancer that May not Be - Rodney Benjamin, M.D.	Indolent Lung Cancer: The Cancer that May not Be - Rodney Benjamin, M.D. - 5	Indolent Lung Cancer: The Cancer that May not Be - Rodney Benjamin, M.D. - 4	Indolent Lung Cancer: The Cancer that May not Be - Rodney Benjamin, M.D. - 3	Indolent Lung Cancer: The Cancer that May not Be - Rodney Benjamin, M.D. - 2	Indolent Lung Cancer: The Cancer that May not Be - Rodney Benjamin, M.D. - 1
IPF Update: Diagnosis in the Community vs ILD Center - David Zisman, M.D.	IPF Update: Diagnosis in the Community vs ILD Center - David Zisman, M.D. - 5	IPF Update: Diagnosis in the Community vs ILD Center - David Zisman, M.D. - 4	IPF Update: Diagnosis in the Community vs ILD Center - David Zisman, M.D. - 3	IPF Update: Diagnosis in the Community vs ILD Center - David Zisman, M.D. - 2	IPF Update: Diagnosis in the Community vs ILD Center - David Zisman, M.D. - 1
Asthma in Hispanics - Veronica Palmero Gonzalez, M.D.	Asthma in Hispanics - Veronica Palmero Gonzalez, M.D. - 5	Asthma in Hispanics - Veronica Palmero Gonzalez, M.D. - 4	Asthma in Hispanics - Veronica Palmero Gonzalez, M.D. - 3	Asthma in Hispanics - Veronica Palmero Gonzalez, M.D. - 2	Asthma in Hispanics - Veronica Palmero Gonzalez, M.D. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

Is this your first time attending this symposium? *

Yes

No

How did you hear about us? *

Would you attend this symposium again next year? *

Yes

No

If you checked "No,” please tell us why: *

Would you recommend this symposium to a colleague? *

If you checked "No,” please explain why you would not recommend this course: *

What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so.

Suggested topics and/or speakers you would like for future symposiums.

Comments

Name

You are here

25th Annual South Miami Hospital Harry Kapp Symposium Evaluation